Nufarm Limited

OTCPK:NUFM.F Stock Report

Market Cap: US$857.3m

Nufarm Valuation

Is NUFM.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NUFM.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: NUFM.F ($2.34) is trading below our estimate of fair value ($9.46)

Significantly Below Fair Value: NUFM.F is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NUFM.F?

Key metric: As NUFM.F is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for NUFM.F. This is calculated by dividing NUFM.F's market cap by their current revenue.
What is NUFM.F's PS Ratio?
PS Ratio0.4x
SalesAU$3.35b
Market CapAU$1.37b

Price to Sales Ratio vs Peers

How does NUFM.F's PS Ratio compare to its peers?

The above table shows the PS ratio for NUFM.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.2x
UAN CVR Partners
1.5xn/aUS$784.4m
IPI Intrepid Potash
1.3x3.9%US$275.9m
BIOX Bioceres Crop Solutions
0.9x9.6%US$389.1m
SMG Scotts Miracle-Gro
1.1x2.2%US$3.9b
NUFM.F Nufarm
0.4x7.6%US$1.4b

Price-To-Sales vs Peers: NUFM.F is good value based on its Price-To-Sales Ratio (0.4x) compared to the peer average (1.2x).

Price to Sales Ratio vs Industry

How does NUFM.F's PS Ratio compare vs other companies in the US Chemicals Industry?

14 CompaniesPrice / SalesEstimated GrowthMarket Cap
TSE Trinseo
0.05x4.1%US$168.87m
AVD American Vanguard
0.2x4.8%US$127.82m
ALTO Alto Ingredients
0.1x3.1%US$113.44m
ENFY Enlightify
0.2xn/aUS$16.12m
NUFM.F 0.4xIndustry Avg. 1.3xNo. of Companies14PS012345+
14 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: NUFM.F is good value based on its Price-To-Sales Ratio (0.4x) compared to the US Chemicals industry average (1.3x).

Price to Sales Ratio vs Fair Ratio

What is NUFM.F's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NUFM.F PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.4x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate NUFM.F's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst NUFM.F forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
US$3.16
0%
25.5%US$5.00US$2.44n/a13
Dec ’25US$2.80
US$3.16
+12.8%
25.5%US$5.00US$2.44n/a13
Nov ’25n/a
US$3.20
0%
26.3%US$5.14US$2.44n/a13
Oct ’25n/a
US$3.26
0%
26.2%US$5.18US$2.46n/a13
Sep ’25US$2.78
US$3.26
+17.2%
26.2%US$5.18US$2.46n/a13
Aug ’25n/a
US$3.85
0%
16.9%US$5.12US$3.19n/a13
Jul ’25n/a
US$3.85
0%
16.9%US$5.12US$3.19n/a13
Jun ’25n/a
US$3.85
0%
16.9%US$5.12US$3.19n/a13
May ’25n/a
US$3.95
0%
12.7%US$5.06US$3.28n/a13
Apr ’25US$3.51
US$3.91
+11.5%
13.0%US$5.02US$3.20n/a13
Mar ’25n/a
US$3.91
0%
13.0%US$5.02US$3.20n/a13
Feb ’25n/a
US$3.91
0%
12.9%US$5.06US$3.22n/a13
Jan ’25US$3.50
US$3.91
+11.7%
12.9%US$5.05US$3.22n/a13
Dec ’24US$2.97
US$3.91
+31.6%
12.9%US$5.05US$3.22US$2.8013
Nov ’24US$2.76
US$3.85
+39.5%
14.8%US$4.86US$3.06n/a12
Oct ’24n/a
US$3.98
0%
13.2%US$4.95US$3.21n/a12
Sep ’24US$3.36
US$4.39
+30.6%
8.5%US$4.99US$3.55US$2.7812
Aug ’24US$3.73
US$4.59
+23.1%
6.5%US$5.13US$4.02n/a11
Jul ’24US$3.39
US$4.76
+40.5%
6.7%US$5.30US$4.16n/a11
Jun ’24n/a
US$4.53
0%
8.0%US$5.12US$3.84n/a12
May ’24n/a
US$4.42
0%
10.8%US$4.99US$3.38n/a12
Apr ’24US$3.61
US$4.42
+22.5%
10.8%US$4.99US$3.38US$3.5112
Mar ’24n/a
US$4.80
0%
10.2%US$5.51US$4.00n/a12
Feb ’24n/a
US$4.80
0%
10.2%US$5.51US$4.00n/a12
Jan ’24US$4.01
US$4.51
+12.4%
10.1%US$5.18US$3.77US$3.5012
Dec ’23US$4.02
US$4.51
+12.3%
9.7%US$5.22US$3.80US$2.9712

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 02:44
End of Day Share Price 2024/12/09 00:00
Earnings2024/09/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nufarm Limited is covered by 31 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stephen WilderAlliance Global Partners
Russell WrightBarclay Pearce Capital Pty Limited
Jonathan SnapeBell Potter